Novel, selective human Sphingosine-1-phosphate subtype 1 (S1P1) receptor agonist. It is used as medicament for treating and/or preventing cardiovascular conditions in patients with Fabry disease.
参考文献
PubChem文献
数据源提供
• Cherezov, V., et al.: Science, Weinreich, M., et al.: J. Immunol., 181, 2265 (2004)